Although several studies have demonstrated that the aggressive types of breast cancer, including HER2-positive breast cancer and TNBC, show higher pCR rates and tumor responses to NAC, the extent of microcalcifications did not correlate with tumor responses. The gene discussed is ERBB2; the disease is neoplasm.